Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Subjects With and Without Atopic Dermatitis

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.740
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Young Children

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Efficacy and Safety of Long-Term Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy With Viaskin® Peanut: Results of the Two-Year Extension of the Vipes Phase IIb Clinical Trial

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Safety and Tolerability of a Novel Peptide-Based Immunotherapy for Peanut Allergy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Management of Atopic Dermatitis: Safety and Efficacy of Phototherapy

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2015English

Peanut Allergy and Oral Immunotherapy

Hong Kong Medical Journal
Medicine
2019English

Transcutaneous Yellow Fever Vaccination of Subjects With or Without Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2014English

The Safety and Efficacy of Sublingual and Oral Immunotherapy for Milk Allergy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2012English

Evaluation of Clinical Changes in Pediatric Patients With Atopic Dermatitis and Respiratory Allergy Receiving Allergen-Specific Immunotherapy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

AR101 Oral Immunotherapy for Peanut Allergy

Pediatrics
Child HealthPediatricsPerinatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy